Random non-fasting C-peptide testing can identify patients with insulin-treated type 2 diabetes at high risk of hypoglycaemia

AIMS/HYPOTHESIS: The aim of this study was to determine whether random non-fasting C-peptide (rCP) measurement can be used to assess hypoglycaemia risk in insulin-treated type 2 diabetes. METHODS: We compared continuous glucose monitoring-assessed SD of blood glucose and hypoglycaemia duration in 17...

Descripción completa

Detalles Bibliográficos
Autores principales: Hope, Suzy V., Knight, Bridget A., Shields, Beverley M., Hill, Anita V., Choudhary, Pratik, Strain, W. David, McDonald, Timothy J., Jones, Angus G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6002965/
https://www.ncbi.nlm.nih.gov/pubmed/28983693
http://dx.doi.org/10.1007/s00125-017-4449-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6002965/
https://www.ncbi.nlm.nih.gov/pubmed/28983693
http://dx.doi.org/10.1007/s00125-017-4449-2

Ejemplares similares